Weekly reads: $1B+ Neurona acquisition, cells + organs = better transplant?, DAXX in germ cells, KRAS
Professor Paul Knoepfler, Ph.D.
The last 3 weeks have been extremely busy with grant work, but one recent bit of news that caught my eye was UCB’s $1 billion+ acquisition of Neurona. Neurona has been on my radar screen for years. Neurona and stem cells for epilepsy Here’s the news: UCB pays $650M+ for Neurona, marking ‘strategic expansion’ into […] The post Weekly reads: $1B+ Neurona acquisition, cells + organs = better transplant?, DAXX in germ cells, KRAS appeared first on The Niche .